Zobrazeno 1 - 5
of 5
pro vyhledávání: '"V. O. Bobrynina"'
Autor:
V. O. Bobrynina
Publikováno v:
Онкогематология, Vol 0, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/4201bb5fa3da4032ad6b9daf4dfc85db
Autor:
M. A. Maschan, L. A. Khachatryan, Yu. V. Skvortsova, E. E. Kurnikova, D. A. Shasheleva, V. O. Bobrynina, D. N. Balashov, E. V. Skorobogatova, D. D. Baydildina, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 45-55 (2014)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the standard curative therapy for juvenile myelomonocytic leukemia (JMML). Seventeen patients with JMML received myeloablative conditioning (busulfan-based — 15, treosulfan-based — 2).
Externí odkaz:
https://doaj.org/article/6e4f8b1ded44412bbefc3903bad71016
Publikováno v:
Онкогематология, Vol 6, Iss 4, Pp 6-11 (2014)
Familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML) is a rare autosomal dominant disorder caused by inherited mutation of RUNX1. To date only 35 families have been described. We report on a family in which number an
Externí odkaz:
https://doaj.org/article/ca82ac24dc844b97a74910e50344a293
Autor:
D. S. Mikhaylenko, M. V. Teleshova, D. V. Perepechin, G D. Efremov, D. Yu. Kachanov, E. V. Raykina, V. O. Bobrynina, S. G. Lavrina, A. M. Mitrofanova, D. M. Konovalov, S. R. Varfolomeeva, B. Ya. Alekseev
Publikováno v:
Onkourologiâ, Vol 13, Iss 2, Pp 14-19 (2017)
The malignant rhabdoid tumor (RT) is one of the most aggressive childhood neoplasm. RTs are characterized by the presence of inactivating mutations in the SMARCB1 (hSNF5/INI1/BAF47) gene – a tumor suppressor localized in 22q11.2. Up to 30 % of RTs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::579e447ba217a789e5551bb411455ec9
https://oncourology.abvpress.ru/oncur/article/view/630
https://oncourology.abvpress.ru/oncur/article/view/630
Autor:
G A Novichkova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, M I Persiantseva, L L Lebedeva, V O Bobrynina, D D Baidildina, O V Goronkova, G G Solopova, L A Khachatryan, U N Petrova, E V Suntsova, I I Kalinina, V V Sinitsyna, E V Skorobogatova, D N Balashov, Z M Dyshlevaya, L N Shelikhova, E E Kurnikova, P E Trakhtman, A A Maschan
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 41-47 (2010)
Aim. To analyze the efficiency of transplantation of the bone marrow from a HLA-compatible unrelated donor and continued immunosuppressive therapy (IST) in children with aplastic anemia (AA) unresponsive to 2 courses of IST. Subjects and methods. The
Externí odkaz:
https://doaj.org/article/a539b74b2830479ca8268ed25335826e